Medical M&A Brokerage Fees: Thorough Explanation of Success Fee Market Rates, Calculation Methods, and Points to Note

📖 Approx. 9 minPublished: 2026.06.20

When considering M&A or business succession for medical institutions, brokerage fees are one of the costs that cannot be ignored. Especially in medical M&A, where the “success fee system” is mainstream, accurately understanding its market rates, calculation methods, and breakdown is essential for selecting the right partner and achieving a smooth M&A. This article provides a detailed explanation, covering basic knowledge about medical M&A brokerage fees, specific calculation examples, other related expenses besides brokerage fees, and points for selecting a brokerage firm, taking into account the unique circumstances of the medical industry.

Basic Structure of Brokerage Fees in Medical M&A

In medical M&A, brokerage fees, similar to M&A for general corporations, often adopt a “success fee system.” This mechanism means that fees are only incurred when the M&A is ultimately successful. The “Lehman formula” is widely used for calculating these success fees. The Lehman formula sets tiered rates based on the value of the transfer price (or total assets transferred), with the rate tending to decrease as the transfer price increases.

Regarding upfront fees, intermediate payments, and monthly retainers, their existence and amounts vary by brokerage firm. Specialized medical M&A brokers provide professional services throughout the entire M&A process, including searching for buyer candidates, negotiation, and due diligence support. Therefore, some cases may involve only success fees, while others may incur some upfront fees or monthly retainers. In particular, for the M&A of medical corporations, the scope of assets to be valued and the procedures differ depending on whether it is a share transfer or a business transfer, which can also affect the basis for calculating fees.

Furthermore, in medical M&A, external environmental changes unique to the industry, such as revisions to medical fee schedules and regional medical care plans, can affect the valuation of medical institutions. To accurately assess these factors and calculate a fair transfer price, the expertise of a brokerage firm well-versed in the medical industry is indispensable.

Scope of “Transfer Price” as the Basis for Success Fee Calculation

The “transfer price” that serves as the basis for calculating success fees does not refer solely to the sale price. Generally, the transfer price includes the sale price of business assets, working capital, and goodwill. However, in medical M&A, there are specific considerations unique to medical corporations, such as the following:

• Valuation of Equity Stakes: For medical corporations with equity stakes, the valuation of these stakes is a crucial element of the transfer price. Various valuation methods, including the net asset value method, income capitalization method, and DCF method, may be used, and the valuation can fluctuate significantly depending on the method adopted.
• Treatment of Fund Repayment Obligations: If a fund system has been introduced, such as during the transition to a medical corporation without equity stakes, consideration must be given to how the obligation to repay the fund affects the transfer price.
• Retirement Allowances for Officers: If retirement allowances for directors, etc., are included in the M&A terms, these may also be treated as part of the effective transfer price.
• Lease Liabilities and Borrowings: The treatment of lease liabilities for medical equipment and borrowings held by the medical institution also impacts the calculation of the transfer price. If these liabilities are assumed by the buyer, they may be deducted from the transfer price or considered separately.

These factors directly influence the final transfer price and, consequently, the brokerage fees. Therefore, it is important to reach a clear agreement with the brokerage firm on the scope considered as the “transfer price” from the early stages of M&A negotiations.

Item	Concept of Transfer Price in General M&A	Specific Considerations in Medical M&A
Business Assets	Land, buildings, machinery, inventory, etc.	Medical equipment, claims for medical fees, pharmaceutical inventory, etc. Facility compliance is also important.
Goodwill	Brand strength, technical capabilities, customer base, etc.	Local reputation, patient base, expertise of doctors and staff, prospects for future medical fee additions, etc.
Working Capital	Cash and deposits, accounts receivable, accounts payable, etc.	Medical fee payment cycles, outstanding receivables, pharmaceutical purchase payables, etc.
Liabilities	Loans, bonds, etc.	Medical equipment lease liabilities, loans specific to medical corporations, fund repayment obligations (for non-equity corporations).
Tax Treatment	Capital gains tax, etc.	Calculation methods for capital gains tax and treatment of business tax differ depending on the type of medical corporation (with or without equity stakes).

Market Rates and Specific Calculation Simulation for Medical M&A Brokerage Fees

The market rate for medical M&A brokerage fees is generally calculated based on the aforementioned Lehman formula. While the rates may vary slightly depending on the brokerage firm and the scale of the M&A, the following rates are often used as a guideline:

• Portion up to 500 million yen: 5%
• Portion from over 500 million yen to 1 billion yen: 4%
• Portion from over 1 billion yen to 5 billion yen: 3%
• Portion from over 5 billion yen to 10 billion yen: 2%
• Portion over 10 billion yen: 1%

However, this is merely a general guideline. Some firms may have a minimum fee, or the rates may be set higher for smaller M&A deals. Additionally, rates may be negotiated individually based on the difficulty of the M&A and the amount of work required.

These calculations are merely examples. In actual contracts, various factors such as the definition of the transfer price, rates, and minimum fees are considered. Before signing a contract, be sure to obtain a detailed estimate and explanation of the fee structure from the brokerage firm.

Expenses Other Than Brokerage Fees in Medical M&A

To ensure the success of a medical M&A, various expenses arise in addition to brokerage fees. It is important to be aware of these costs as part of the overall M&A expenses in advance.

1. Due Diligence (DD) Costs: These are the costs incurred by the potential buyer to conduct a detailed investigation of the target medical institution’s finances, legal affairs, taxes, labor, and specific operational aspects (medical practice results, facility standards, licenses, compliance with regional medical care plans, etc.). This includes fees for professionals such as certified public accountants, lawyers, tax accountants, social insurance labor consultants, and medical consultants. Depending on the scale and scope, these costs can range from several million to tens of millions of yen.
2. Consultation and Retainer Fees for Experts: These are fees incurred when requesting consultations or contract reviews regarding M&A from your company’s regular tax accountants or lawyers, separate from the M&A brokerage firm.
3. Real Estate Appraisal Fees: These fees are incurred when an appraisal of real estate owned by the medical institution is necessary.
4. Registration Fees: These include judicial scrivener fees and registration license taxes for changes in corporate members or officers of the medical corporation, and title transfers of real estate.
5. PMI (Post Merger Integration) Costs: These are costs incurred after the M&A is executed for organizational integration, system integration, review of business processes, etc. In particular, integrating different medical institution cultures is a critical factor that can determine the success or failure of an M&A.

These expenses can vary significantly depending on the scale and complexity of the M&A and the number of professionals involved. Medical M&A, in particular, requires a deep understanding of medical laws, related regulations, and the medical fee system, making highly specialized DD indispensable and consequently leading to higher costs.

Points and Precautions for Selecting a Medical M&A Brokerage Firm

Choosing the right brokerage firm is directly linked to the success of a medical M&A. Please consider the following points carefully when making your selection.

• 
  Expertise and Track Record in the Medical Industry

  Verify their understanding of the complex regulations and customs unique to the medical industry, such as types of medical corporations (with or without equity stakes), medical fee revisions, facility standards, licenses, and regional medical care plans. Past M&A support experience in the medical sector is also an important factor.

• 
  Experience and Reliability of the Representative

  M&A is a long-term process, and a trusting relationship with the representative is crucial. Assess their expertise, communication skills, negotiation abilities, and integrity.

• 
  Transparency of Fee Structure

  Confirm that the fee structure, including the calculation basis for success fees, the presence of upfront or intermediate payments, and minimum fees, is clear and acceptable. Ensure that the contract covers all aspects to avoid unexpected additional costs later.

• 
  Exclusivity Period and Termination Conditions

  Many brokerage firms require an exclusive contract. Confirm that the duration and termination conditions are appropriate. You should also check the termination process in case the relationship with the brokerage firm does not go well.

Considerations and Risks for Reducing Brokerage Fees

Brokerage fees represent a significant portion of M&A costs, so it is natural to want to reduce them. However, hasty cost reductions can lead to M&A failure or subsequent troubles.

First, it is important to understand the difference between a brokerage contract and a Financial Advisor (FA) contract. A brokerage contract typically involves earning fees from both the seller and the buyer (“dual agency”), while an FA contract involves advising from the perspective of one party, potentially reducing the risk of conflicts of interest. However, with an FA contract, the buyer and seller each hire an FA, which tends to increase overall M&A costs. In medical M&A, brokerage contracts are common due to the prevalence of small and medium-sized deals, but it is crucial to carefully review the contract details and assess whether the brokerage firm maintains a stance of fairly balancing the interests of both parties.

Additionally, some consider “self-M&A.” However, this carries significant risks if professional knowledge and experience are lacking, including legal and tax risks, and losses due to the inability to perform appropriate business valuations. Medical M&A, in particular, involves numerous points that specialists must carefully consider, such as a wide range of regulations including the Medical Care Act, the Pharmaceutical and Medical Device Act, and the Long-Term Care Insurance Act, the impact of medical fee revisions, and consistency with regional medical care plans.

Negotiating fees is one option, but excessive discount negotiations may affect the quality of services provided. Instead of choosing a brokerage firm solely based on low fees, selecting a partner who can maximize cost-effectiveness by comprehensively evaluating their track record, expertise, and reliability will ultimately increase the probability of M&A success and lead to long-term benefits.

While medical M&A brokerage fees are generally based on a success fee system, the scope of the “transfer price” used for calculation and the rates in the Lehman formula can vary by brokerage firm. Furthermore, various costs arise in addition to brokerage fees, such as due diligence expenses and professional fees. Comprehensively understanding these costs and selecting a brokerage firm with specialized knowledge and a proven track record in the medical industry is key to a successful M&A. At M&A Medical, specialists focused on M&A and business succession for medical institutions provide optimal proposals tailored to your situation. We also accept consultations regarding fee structures and M&A in general, so please feel free to contact us.

---

For Medical Succession Consultations, Contact M&A Medical

M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support organization certified by the Small and Medium Enterprise Agency, we support the transfer of clinics and medical corporations facing succession issues, as well as strategic acquisitions, on a success fee basis.

• Initial consultation and preliminary assessment are free
• No upfront fees or monthly charges (success fee only)
• Strict confidentiality (proceeds after signing NDA)
• Support available nationwide across all 47 prefectures and all medical specialties

Whether you “just want to know the market price,” “have no successor,” or “are considering joining a group,” it is best to consult with us early in your consideration phase.

Apply for a Free Consultation